Russell Investments Group’s SOPHiA GENETICS SOPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$340 Hold
59
﹤0.01% 4219
2026
Q1
$292 Hold
59
﹤0.01% 4125
2025
Q4
$276 Buy
59
+37
+168% +$168 ﹤0.01% 4100
2025
Q3
$105 Hold
22
﹤0.01% 4104
2025
Q2
$68 Sell
22
-30
-58% -$89 ﹤0.01% 3814
2025
Q1
$173 Hold
52
﹤0.01% 3737
2024
Q4
$160 Hold
52
﹤0.01% 3664
2024
Q3
$190 Hold
52
﹤0.01% 3638
2024
Q2
$238 Hold
52
﹤0.01% 3542
2024
Q1
$256 Hold
52
﹤0.01% 3264
2023
Q4
$245 Hold
52
﹤0.01% 3172
2023
Q3
$132 Hold
52
﹤0.01% 3508
2023
Q2
$233 Buy
+52
New +$235 ﹤0.01% 3413

Other funds holding SOPH

Russell Investments Group's SOPH Position: Q2 2026 in Review

Russell Investments Group held its SOPHiA GENETICS (SOPH) position steady in Q2 2026 at 59 shares worth $340. The position accounts for ﹤0.01% of the portfolio, ranked #4219.

Russell Investments Group first reported a position in SOPH in Q2 2023 and has held it in 13 quarters since. 25 funds tracked by Wall St. Rank hold SOPH as of Q2 2026.

  • Russell Investments Group held 59 shares of SOPHiA GENETICS worth $340 as of Q2 2026.
  • Russell Investments Group left its SOPHiA GENETICS share count unchanged in Q2 2026.
  • SOPHiA GENETICS made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #4219 holding.
  • Russell Investments Group first reported a position in SOPHiA GENETICS in Q2 2023 and has held it in 13 quarters since.
  • 25 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.